Related Experiment Videos
Association of suboptimal blood pressure control with body size and metabolic abnormalities
Oreste Arcucci1, Giovanni de Simone, Raffaele Izzo
1Department of Internal Medicine, Cardiovascular and Immunological Pathology, Geriatrics, Cardiac Surgery, Federico II University Hospital, Naples, Italy.
Insights
Poor blood pressure control is linked to metabolic syndrome. Higher numbers of metabolic risk factors worsen hypertension management, even with more medications.
Area of Science:
- Cardiology
- Metabolic Health
- Hypertension Management
Background:
- Blood pressure control remains a significant public health challenge.
- The influence of metabolic abnormalities on hypertension control is not well understood.
- This study investigates the link between metabolic risk factors and blood pressure control in hypertensive patients.
Purpose of the Study:
- To evaluate the relationship between metabolic risk factors and blood pressure control.
- To determine if metabolic syndrome impacts hypertension management.
- To assess the association between the number of metabolic risk factors and blood pressure control.
Main Methods:
- Analysis of 4551 hypertensive patients from a Hypertension Centre.
- Utilized a modified Adult Treatment Panel III definition for metabolic syndrome, using BMI instead of waist circumference.
- Blood pressure control defined as <140/90 mmHg, with analysis adjusted for age, sex, and medication count.
Main Results:
- Metabolic syndrome was present in 31.72% of subjects.
- Patients with metabolic syndrome had a 43% higher probability of uncontrolled blood pressure, independent of other factors.
- Uncontrolled blood pressure increased significantly with more metabolic risk factors and was associated with higher medication use.
Conclusions:
- Suboptimal blood pressure control is independently associated with metabolic syndrome.
- Hypertension management deteriorates as the number of associated metabolic risk factors increases.
- Increased medication use does not fully overcome the negative impact of metabolic risk factors on blood pressure control.
Background:
Blood pressure control is disappointingly suboptimal in populations. Whether metabolic abnormalities influence blood pressure control is unclear. We evaluated the relationship between metabolic risk factors and blood pressure control in a large population of patients with hypertension.
Methods:
From our Hypertension Centre, 4551 subjects (43.4% women; age 51 +/- 12 years) were selected with available data for metabolic and cardiovascular evaluation (no prevalent cardiovascular disease), at the last control visit. A modified Adult Treatment Panel III definition of metabolic syndrome was adopted changing waist girth for body mass index (>or= 30 kg/m2). Blood pressure was considered controlled when supine office blood pressure was below 140/90 mmHg, or uncontrolled if this target was not achieved. Blood pressure control has been evaluated in relation to metabolic risk factors, adjusting for age, sex, and the number of antihypertensive medications.
Results:
The metabolic syndrome phenotype was found in 1444 individuals (31.72%). The probability of uncontrolled blood pressure was 43% higher in patients with the metabolic syndrome than in those without, independently of covariates. This probability was also confirmed in 728 untreated patients. The probability of uncontrolled blood pressure significantly and independently increased with the increasing number of metabolic risk factors. Uncontrolled blood pressure was also independently associated with the prescription of more medications.
Conclusion:
Insufficient control of blood pressure is independently associated with the presence of the metabolic syndrome. Blood pressure control worsens with the increasing number of metabolic risk factors associated with hypertension, despite the use of a greater number of medications.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Factors affecting Blood pressure
Physiological Factors:
Drug Dosing: Obese Patients
Measurement of Blood Pressure
Coronary Artery Disease I: Introduction